A single-cell landscape of high-grade serous ovarian cancer

A single-cell landscape of high-grade serous ovarian cancer

© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Malignant abdominal fluid (ascites) frequently develops in women with advanced high-grade serous ovarian cancer (HGSOC) and is associated with drug resistance and a poor prognosis1. To comprehensively characterize the HG...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Springer Science and Business Media LLC 2021
Online Access:	https://hdl.handle.net/1721.1/136662

Similar Items

A single-cell landscape of high-grade serous ovarian cancer
by: Izar, Benjamin, et al.
Published: (2022)

Immune cell landscapes are associated with high-grade serous ovarian cancer survival
by: Guoan Zhang, et al.
Published: (2024-07-01)

Integrating single-cell and spatial transcriptomic analysis to unveil heterogeneity in high-grade serous ovarian cancer
by: Haixia Luo, et al.
Published: (2024-06-01)

Fallopian tube single cell analysis reveals myeloid cell alterations in high-grade serous ovarian cancer
by: Joshua Brand, et al.
Published: (2024-03-01)

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
by: Kosuke Kanno, et al.
Published: (2024-08-01)

Immunohistochemical Expression of p53 Gene and Clinicopathological Assessment of Low-grade Serous Ovarian Cancer and High-grade Serous Ovarian Cancer: A Cohort Study
by: Geeta Bazard, et al.
Published: (2024-12-01)

MicroRNA expression and activity in high-grade serous ovarian cancer
by: Howe, EA
Published: (2012)

Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
by: Samar Elorbany, et al.
Published: (2024-11-01)

Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Published: (2018)

The chromatin landscape of high-grade serous ovarian cancer metastasis identifies regulatory drivers in post-chemotherapy residual tumour cells
by: Croft, W, et al.
Published: (2024)

The chromatin landscape of high-grade serous ovarian cancer metastasis identifies regulatory drivers in post-chemotherapy residual tumour cells
by: W. Croft, et al.
Published: (2024-09-01)

Targeted therapy in high grade serous ovarian Cancer: A literature review
by: Kaitlyn Dinkins, et al.
Published: (2024-08-01)

Examining the evidence for immune checkpoint therapy in high-grade serous ovarian cancer
by: A.E. Connor, et al.
Published: (2024-10-01)

High-Grade Serous Ovarian Cancer during Pregnancy: From Diagnosis to Treatment
by: Gregor Vivod, et al.
Published: (2024-04-01)

Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
by: Julia McAdams, et al.
Published: (2024-09-01)

Establishment of cancer cell line originating from a patient with high-grade serous ovarian carcinoma
by: Nguyen Thuy Linh, et al.
Published: (2023-09-01)

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.
by: Roland F Schwarz, et al.
Published: (2015-02-01)

High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive
by: Jacek Wilczyński, et al.
Published: (2024-01-01)

Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review.
by: Chen, F, et al.
Published: (2017)

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
by: Shuang Zhang, et al.
Published: (2019-11-01)

NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
by: Cassie Liu, et al.
Published: (2024-05-01)

RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells
by: Yuanzhi Chen, et al.
Published: (2023-12-01)

The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer
by: Mengqi Deng, et al.
Published: (2025-03-01)

Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction
by: Oz Kilim, et al.
Published: (2025-01-01)

Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer
by: Tingjie Wang, et al.
Published: (2024-11-01)

Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo
by: Li Yang, et al.
Published: (2024-08-01)

Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
by: Michelle Greenman, et al.
Published: (2024-08-01)

Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
by: Huiping Liu, et al.
Published: (2023-12-01)

Decreased Levels of GSH Are Associated with Platinum Resistance in High-Grade Serous Ovarian Cancer
by: Daniela Criscuolo, et al.
Published: (2022-08-01)

A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers
by: Laurel K. Berry, et al.
Published: (2024-11-01)

The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer
by: Siddik Sarkar, et al.
Published: (2024-08-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
by: I. S. Shponka, et al.
Published: (2020-04-01)

Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy
by: Raphael Gronauer, et al.
Published: (2024-11-01)

Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer
by: Kate E. Meeson, et al.
Published: (2024-08-01)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
by: Sharon E Robertson, et al.
Published: (2023-01-01)

Disparities in treatment modalities and survival among older patients with high-grade serous ovarian cancer
by: Yan Cai, et al.
Published: (2024-02-01)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
by: Sharon E. Robertson, et al.
Published: (2023-01-01)

ScHGSC-IGDC: Identifying genes with differential correlations of high-grade serous ovarian cancer based on single-cell RNA sequencing analysis
by: Yuanqi Li, et al.
Published: (2024-06-01)

Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma
by: Andrea Flesken-Nikitin, et al.
Published: (2024-10-01)

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.
by: Zheng Feng, et al.
Published: (2016-01-01)